Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.39 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.39 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GGH | Q92820 | 1/20 | 0.38 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.35 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21837502 | 1.00 | CHRNB2 (0.41) | CHRNB2CHRNB4CHRNA4FOLH1NAALAD2 | |
| SCHEMBL25355432 | 0.89 | CHRNB2 (0.52) | CHRNB2CHRNB4CHRNA4FOLH1NAALAD2 | |
| SCHEMBL25355433 | 0.89 | CHRNB2 (0.52) | CHRNB2CHRNB4CHRNA4FOLH1NAALAD2 | |
| SCHEMBL31369564 | 0.87 | CHRNB2 (0.46) | CHRNB2CHRNB4CHRNA4FOLH1ALDH1A1 | |
| SCHEMBL26378508 | 0.79 | CHRNB2 (0.38) | CHRNB2CHRNB4CHRNA4ALDH1A1 | |
| SCHEMBL25179566 | 0.79 | KDM4E (0.33) | CHRNB2CHRNB4CHRNA4FOLH1NAALAD2 | |
| SCHEMBL25179567 | 0.79 | KDM4E (0.33) | CHRNB2CHRNB4CHRNA4FOLH1NAALAD2 | |
| SCHEMBL180085 | 0.79 | FOLH1 (0.61) | FOLH1NAALAD2RIMKLAGGHANPEP | |
| SCHEMBL162038 | 0.79 | FOLH1 (0.61) | FOLH1NAALAD2RIMKLAGGHANPEP | |
| SCHEMBL162037 | 0.79 | FOLH1 (0.61) | FOLH1NAALAD2RIMKLAGGHANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-4534524-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PeptiDream Inc. (JP) | 2025-04-09 | — | — | EP | disclosed |
| US-20200131669-A1 | CYCLIC PEPTIDE COMPOUND HAVING HIGH MEMBRANE PERMEABILITY, AND LIBRARY CONTAINING SAME | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2020-04-30 | — | — | US | disclosed |
| EP-3636807-A1 | CYCLIC PEPTIDE COMPOUND HAVING HIGH MEMBRANE PERMEABILITY, AND LIBRARY CONTAINING SAME | Chugai Seiyaku Kabushiki Kaisha (JP) | 2020-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | CHRNB2 4184/4885CHRNB4 3514/4885CHRNA4 2500/4885 |
| US-20200131669-A1 | CYCLIC PEPTIDE COMPOUND HAVING HIGH MEMBRANE PERMEABILITY, AND LIBRARY CONTAINING SAME | VIP, SLC7A1, TRPV1 | CHRNB2 3094/4885CHRNB4 2787/4885CHRNA4 3269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.